← Back to Search

NIATx-TI with Product Training/On-line Support for Substance Use Disorder

N/A

Waitlist Available

Led By Todd Molfenter, Ph.D.

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up collected during months 7, 18, 30, and 42

Awards & highlights

Study Summary

This trial will compare two ways of increasing use of a smartphone app to help people with addiction. One method is typical product training combined with NIATx-TI, which is a framework for adopting new technologies.

Eligible Conditions

Substance Use Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected during months 7, 18, 30, and 42

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected during months 7, 18, 30, and 42

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected during months 7, 18, 30, and 42 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Reach: As assessed by the number of days that participants use the A-CHESS

Reach: As assessed by the percentage of participants that download the A-CHESS app

Secondary outcome measures

A-CHESS/NIATx Implementation Fidelity (Survey)

Adoption - The percentage of counselors using A-CHESS will be assessed via the organizational survey and A-CHESS logs

Adoption: Number of days each counselor used the A-CHESS

+4 more

Other outcome measures

Supplement 1 - Understand impact of ACHESS on pt anxiety and loneliness during COVID-19 pandemic

Supplement 2 - Understand how treatment organizations and staff used ACHESS during COVID pandemic

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: NIATx-TI FrameworkExperimental Treatment1 Intervention

Sites in the NIATx-TI Arm will receive product training/online support, and training in the NIATx-TI framework. The NIATx-TI framework will include a pre-implementation (planning) phase, and post-implementation (problem-solving) phase, with training delivered by a NIATx-TI coach.

Group II: TAU/ControlActive Control1 Intervention

Sites in the Treatment as Usual (TAU)/Control Arm will receive product training/online support. Sites in the TAU/Control Arm will participate in a one-day product implementation or training session.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

NIATx-TI with Product Training/On-line Support

2019

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,182 Previous Clinical Trials

3,167,348 Total Patients Enrolled

University of IowaOTHER

446 Previous Clinical Trials

879,463 Total Patients Enrolled

Iowa Department of Public HealthUNKNOWN

1 Previous Clinical Trials

426 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the intention of this experiment?

"This study will measure its efficacy over a 52-month period, with the primary outcome being assessed by the percentage of participants that download A-CHESS. Secondary outcomes include survey data on organizational readiness and financial resource availability as well as an evaluation of fidelity to NIATx Technology Implementation (NIATx-TI) process."

Answered by AI

What is the current scope of this experiment's implementation?

"This medical trial is being conducted across 49 different sites, including Rockwell City, Webster City and Iowa City. To reduce strain from travel requirements, applicants should select the location nearest to them for participation."

Answered by AI

Are there still vacancies available for enrollees in this research effort?

"According to the clinicaltrials.gov database, this trial is not presently recruiting patients. The study was initially posted on September 3rd 2019 and last updated November 17th 2022. It is worth noting that there are 359 other trials actively enrolling at present."

Answered by AI